Intelligent Drug Design
Frontier AI Infrastructure & Physics Runtimes for Autonomous Drug Discovery
Generative models and quantum chemistry in air-gapped runtimes that learn from project data without raw IP leaving.
Securely generating novel or optimized molecules from protected project data
Generative models and quantum chemistry runtimes learn from internal project data in a secure edge environment deployed for you.
Qubigen automatically tailors these AI models for your exclusive use to generate and prioritize novel molecular structures.
Decentralized Edge Learning
Qubigen’s decentralized edge architecture allows high-performing tensor models to learn directly from distributed internal project data without centralizing raw IP or exposing sensitive results.
Autonomous Generative Execution
Driven by proprietary tensor architectures and automated computational workflows, the platform generates high-potency, synthetically feasible drug candidates tailored specifically to complex target protein structures.
Precision SAR & Candidate Optimization
Traditional structure-activity relationship (SAR) workflows are iterative bottlenecks prone to high candidate attrition. Qubigen accelerates candidate prioritization and minimizes wasted synthesis cycles by combining generative tensor models with parallelized, first-principles quantum chemistry (QM) runtimes.
Air-Gapped Security
Sensitive project data never leaves your secure environment. All execution, model fine-tuning, and quantum mechanics calculations operate within isolated, air-gapped runtimes, ensuring complete client-side data isolation.
Collaborations & Partnerships
Partner Locations
Partner Institutes
Unleashing Technological Excellence
10+
AI Drug Discovery Projects
50K+
Virtual Screening Simulations
100M+
Quantum Chemistry Computations
22
50+
5
Innovative Solutions